Asthma and infections: An update on asthma exacerbations

Clinical Pulmonary Medicine

Volumn 20, Issue 2, 2013, Pages 56-60

  Sykes, Annemarie ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

Asthma exacerbations; Atypical bacteria; Interferon; Rhinovirus

Indexed keywords

ALLERGEN; BETA INTERFERON; GAMMA INTERFERON; VIRUS RNA;

ADENOVIRUS INFECTION; APOPTOSIS; ARTICLE; ASTHMA; AUTUMN; BACTERIAL INFECTION; BRONCHUS MUCOSA; CHLAMYDOPHILA PNEUMONIAE; COMMON COLD; CORONAVIRUS INFECTION; DISEASE ASSOCIATION; DISEASE EXACERBATION; DISEASE SEVERITY; HAEMOPHILUS INFECTION; HUMAN; INFECTION RISK; INFLUENZA; INTERFERON PRODUCTION; METAPNEUMOVIRUS INFECTION; PARAINFLUENZA VIRUS INFECTION; PICORNAVIRUS INFECTION; RESPIRATORY SYNCYTIAL VIRUS INFECTION; RESPIRATORY TRACT INFECTION; SEASONAL VARIATION; SPRING; VIRAL RESPIRATORY TRACT INFECTION;

EID: 84874907258     PISSN: 10680640     EISSN: 15365956     Source Type: Journal    
DOI: 10.1097/CPM.0b013e318285c4e0     Document Type: Article

References (50)

1. GINA. Global Strategy for Asthma Managment and Prevention, 2011. Available at: http://www.ginasthma.org. GINA
2. Rabe KF, Vermeire PA, Soriano JB, et al. Clinical management of asthma in 1999. The Asthma Insights and Reality in Europe (AIRE) study. Eur Respir J. 2000;16:802-807. (Pubitemid 32049363)
3. Weiss KB, Sullivan SD. The health economics of asthma and rhinitis. I. Assessing the economic impact. J Allergy Clin Immunol. 2001;107:3-8. (Pubitemid 32105235)
4. O'Hollaren MT, Yunginger JW, Offord KP, et al. Exposure to an aeroallergen as a possible precipitating factor in respiratory arrest in young patients with asthma. N Engl J Med. 1991;324:359-363.
5. Corne JM, Marshall C, Smith S, et al. Frequency, severity, and duration of rhinovirus infections in asthmatic and non-asthmatic individuals: a longitudinal cohort study. Lancet. 2002;359:831-834. (Pubitemid 34233753)
6. Johnston SL, Pattemore PK, Sanderson G, et al. Community study of role of viral infections in exacerbations of asthma in 9-11 year old children. BMJ. 1995;310:1225-1229.
7. Pauwels RA, Lofdahl CG, Postma DS, et al. Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group. NEJM. 1997;337:1405-1411.
8. Lambert HP, Stern H. Infective factors in exacerbations of bronchitis and asthma. BMJ. 1972;3:323-327.
9. Bella J, Rossmann MG. Review: rhinoviruses and their ICAM receptors. J Struct Biol. 1999;128:69-74. (Pubitemid 30013434)
10. Khetsuriani N, Kazerouni NN, Erdman DD, et al. Prevalence of viral respiratory tract infections in children with asthma. J Allergy Clin Immunol. 2007;119:314-321. (Pubitemid 46204808)
11. Williams JV, Crowe JE Jr, Enriquez R, et al. Human metapneumovirus infection plays an etiologic role in acute asthma exacerbations requiring hospitalization in adults. J Infect Dis. 2005;192:1149-1153. (Pubitemid 41368412)
12. Johnston NW, Johnston SL, Duncan JM, et al. The September epidemic of asthma exacerbations in children: a search for etiology. J Allergy Clin Immunol. 2005;115:132-138. (Pubitemid 40075433)
13. Nicholson KG, Kent J, Ireland DC. Respiratory viruses and exacerbations of asthma in adults. BMJ. 1993;307:982-986. (Pubitemid 23306765)
14. Libster R, Coviello S, Cavalieri ML, et al. Pediatric hospitalizations due to influenza in 201. in Argentina. NEJM. 2010;363:2472-2473.
15. O'Riordan S, Barton M, Yau Y, et al. Risk factors and outcomes among children admitted to hospital with pandemic H1N1 influenza. CMAJ. 2010;182:39-44.
16. Johnston NW, Johnston SL, Norman GR, et al. The September epidemic of asthma hospitalization: school children as disease vectors. J Allergy Clin Immunol. 2006;117:557-562. (Pubitemid 43340218)
17. Lau SK, Yip CC, Lin AW, et al. Clinical and molecular epidemiology of human rhinovirus C in children and adults in Hong Kong reveals a possible distinct human rhinovirus C subgroup. J Infect Dis. 2009;200:1096-1103.
18. Miller EK, Khuri-Bulos N, Williams JV, et al. Human rhinovirus C associated with wheezing in hospitalised children in the Middle East. J Clin Virol. 2009;46:85-89.
19. Message SD, Laza-Stanca V, Mallia P, et al. Rhinovirus-induced lower respiratory illness is increased in asthma and related to virus load and Th1/2 cytokine and IL-10 production. Proc Natl Acad Sci USA. 2008;105:13562-13567.
20. Contoli M, Message SD, Laza-Stanca V, et al. Role of deficient type III interferon-lambda production in asthma exacerbations. Nat Med. 2006;12:1023-1026. (Pubitemid 44353382)
21. Isaacs A, Lindenmann J. Virus interference. I. The interferon. Proc R Soc Lond B Biol Sci. 1957;147:258-267.
22. Fensterl V, Sen GC. Interferons and viral infections. Biofactors. 2009;35:14-20.
23. Sheppard P, Kindsvogel W, Xu W, et al. IL-28, IL-29 and their class II cytokine receptor IL-28R. Nat Immunol. 2003;4:63-68. (Pubitemid 36104710)
24. Khaitov MR, Laza-Stanca V, Edwards MR, et al. Respiratory virus induction of alpha-, beta- and lambda-interferons in bronchial epithelial cells and peripheral blood mononuclear cells. Allergy. 2009;64:375-386.
25. Slater L, Bartlett NW, Haas JJ, et al. Co-ordinated role of TLR3, RIG-I and MDA5 in the innate response to rhinovirus in bronchial epithelium. PLoS Pathog. 2010;6:e1001178.
26. Bufe A, Gehlhar K, Grage-Griebenow E, et al. Atopic phenotype in children is associated with decreased virus-induced interferonalpha release. Int Arch Allergy Immunol. 2002;127:82-88. (Pubitemid 34224957)
27. Gehlhar K, Bilitewski C, Reinitz-Rademacher K, et al. Impaired virus-induced interferon-alpha2 release in adult asthmatic patients. Clin Exp Allergy. 2006;36:331-337. (Pubitemid 43344714)
28. Gill MA, Bajwa G, George TA, et al. Counterregulation between the FcepsilonRI pathway and antiviral responses in human plasmacytoid dendritic cells. J Immunol. 2010;184:5999-6006.
29. Wark PA, Grissell T, Davies B, et al. Diversity in the bronchial epithelial cell response to infection with different rhinovirus strains. Respirology. 2009;14:180-186.
30. Wark PA, Johnston SL, Bucchieri F, et al. Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus. J Exp Med. 2005;201:937-947. (Pubitemid 40524463)
31. Sykes A, Edwards M, Macintyre J, et al. RV16 induced interferons-a and -b are deficient in BAL cells in asthma. J Allergy Clin Immnunol. 2012;129:1506-1514.
32. Iikura K, Katsunuma T, Saika S, et al. Peripheral blood mononuclear cells from patients with bronchial asthma show impaired innate immune responses to rhinovirus in vitro. Int Arch Allergy Immunol. 2011;155(suppl 1):27-33.
33. Forbes RL, Gibson PG, Murphy VE, et al. Impaired type I and III interferon response to rhinovirus infection during pregnancy and asthma. Thorax. 2012;67:209-214.
34. Hilty M, Burke C, Pedro H, et al. Disordered microbial communities in asthmatic airways. PloS One. 2010;5:e8578.
35. Klemets P, Lyytikainen O, Ruutu P, et al. Risk of invasive pneumococcal infections among working age adults with asthma. Thorax. 2010;65:698-702.
36. Pilishvili T, Zell ER, Farley MM, et al. Risk factors for invasive pneumococcal disease in children in the era of conjugate vaccine use. Pediatrics. 2010;126:e9-e17.
37. Talbot TR, Hartert TV, Mitchel E, et al. Asthma as a risk factor for invasive pneumococcal disease. NEJM. 2005;352:2082-2090. (Pubitemid 40667531)
38. Wood LG, Simpson JL, Hansbro PM, et al. Potentially pathogenic bacteria cultured from the sputum of stable asthmatics are associated with increased 8-isoprostane and airway neutrophilia. Free Radic Res. 2010;44:146-154.
39. Biscione GL, Corne J, Chauhan AJ, et al. Increased frequency of detection of Chlamydophila pneumoniae in asthma. Eur Respir J. 2004;24:745-749. (Pubitemid 39504426)
40. Kraft M, Cassell GH, Pak J, et al. Mycoplasma pneumoniae and Chlamydia pneumoniae in asthma: effect of clarithromycin. Chest. 2002;121:1782-1788. (Pubitemid 34634396)
41. Huang YJ, Nelson CE, Brodie EL, et al. Airway microbiota and bronchial hyperresponsiveness in patients with suboptimally controlled asthma. J Allergy Clin Immnunol. 2011;127:372-381, e1-e3.
42. Johnston SL, Blasi F, Black PN, et al. The effect of telithromycin in acute exacerbations of asthma. NEJM. 2006;354:1589-1600.
43. Gielen V, Johnston SL, Edwards MR. Azithromycin induces antiviral responses in bronchial epithelial cells. Eur Respir J. 2010;36:646-654.
44. Cunningham AF, Johnston SL, Julious SA, et al. Chronic Chlamydia pneumoniae infection and asthma exacerbations in children. Eur Respir J. 1998;11:345-349. (Pubitemid 28108347)
45. Wark PA, Johnston SL, Simpson JL, et al. Chlamydia pneumoniae immunoglobulin A reactivation and airway inflammation in acute asthma. Eur Respir J. 2002;20:834-840. (Pubitemid 35175117)
46. Pulimood TB, Corden JM, Bryden C, et al. Epidemic asthma and the role of the fungal mold Alternaria alternata. J Allergy Clin Immnunol. 2007;120:610-617. (Pubitemid 47320756)
47. Marks GB, Colquhoun JR, Girgis ST, et al. Thunderstorm outflows preceding epidemics of asthma during spring and summer. Thorax. 2001;56:468-471. (Pubitemid 32521365)
48. Green RM, Custovic A, Sanderson G, et al. Synergism between allergens and viruses and risk of hospital admission with asthma: case-control study. BMJ. 2002;324:763.
49. Murray CS, Poletti G, Kebadze T, et al. Study of modifiable risk factors for asthma exacerbations: virus infection and allergen exposure increase the risk of asthma hospital admissions in children. Thorax. 2006;61:376-382. (Pubitemid 43723318)
50. Sykes A, Johnston SL. Etiology of asthma exacerbations. J Allergy Clin Immnunol. 2008;122:685-688.